The agreement covers licensing rights in North America for Duchenne muscular dys...
Novartis has reported net sales of $13.62bn in Q2 of 2023, indicating a 7% rise ...
Advent Therapeutics has received a grant worth $3m from the US NIH for expeditin...
The Phase I trial evaluates the combination Telix’s targeted radiation therapy w...
Flagship Pioneering has entered into a collaboration with Pfizer to develop a ne...
Sen. Bernie Sanders added three drug shortage measures to a pandemic-preparednes...
Most everything is looking up for Orexo, the company reported on its earnings ca...
Low-income immigrant mothers often lose insurance eligibility as soon as they gi...
Pharmaceutical giant Johnson & Johnson is the third drugmaker to sue the Biden a...
“GPT-4, being trained off of our own textual communication, shows the same — or ...
For the third time this year, Novartis has been rebuked by a U.K. trade group fo...
Join STAT for a discussion of what's next for biosimilars, and what key signals ...
The benefits and risks of an Eli Lilly treatment for Alzheimer's were confirmed ...
Long-running firm ARCH Venture Partners has topped STAT's annual ranking of biot...
The new Pfizer partnership with Flagship will fund the development of up to 10 d...
Neumora, a privately held biotech company, is moving into the final phase of tes...
